Unlock Your Health: New Study Maps Genetic Metabolism
New research highlights the profound influence of genetic metabolism on human health. Scientists have identified approximately 750 genes that significantly contribute to human metabolism by affecting the levels of 250 crucial molecules in the blood, including vital lipids and amino acids. These groundbreaking findings are believed to be universally applicable across various ancestries and genders, promising widespread implications for medical understanding and treatment.
Understanding the Study’s Scope
Researchers from the Berlin Institute of Health at Charité-University Medicine Berlin, Germany, and Queen Mary University in London led this comprehensive study. The team analyzed genetic data from around 4.5 lakh individuals of European, African, and Asian ancestry, sourced from the UK Biobank. Large-scale biobanks, such as the UK Biobank, are indeed instrumental in advancing our understanding of genetic influences on health and disease.
The results were published in the esteemed journal Nature Genetics. These findings reveal that genes governing metabolite activity show remarkable similarity across ancestries and genders. Therefore, this consistency strongly suggests that the study’s conclusions can be broadly applied to a wider global population. This makes the research highly impactful for healthcare professionals worldwide.
Genetic Influences on Disease Risk
Significantly, the identified genes included several previously unknown to contribute to metabolism. Consequently, these discoveries provide novel insights into complex metabolic pathways and ultimately human health. The researchers pinpointed 29,824 locus-metabolite associations, mapping to 753 regions where effects generally remained consistent across genders and major ancestral groups within the UK Biobank.
Furthermore, the team demonstrated a crucial overlap between genes controlling blood metabolites and disease risk, suggesting these genetic factors can increase an individual’s susceptibility to various conditions. For example, the gene ‘VEGFA’, newly identified by the authors as potentially regulating aspects of high-density lipoprotein (HDL) cholesterol, may facilitate the development of new medications specifically designed to prevent heart diseases.
Insights for Future Therapeutics
Martijn Zoodsma, a postdoctoral researcher and lead author at the Berlin Institute of Health, commented on the significance: “We are now able to map systematically the genetic control of hundreds of blood molecules, at unprecedented scale. This provides a powerful reference to understand disease risk and identify genes that contribute to variability in metabolism.”
Maik Pietzner, a senior author and professor for health data modeling at BIH and Queen Mary’s Precision Health University Research Institute (PHURI), emphasized the ongoing challenge of heart diseases. He noted that despite advancements in blood lipid-lowering medications like statins, which have undoubtedly saved numerous lives, heart diseases continue to be a major killer. Pietzner concluded, “Our results highlight potential avenues that will hopefully lead to new medicines to prevent even more deaths from lipid plaques building in people’s arteries.”
Frequently Asked Questions
Q1: What is the main finding of the study regarding genetic metabolism?
The study identified approximately 750 genes that influence human metabolism by impacting the blood levels of about 250 molecules, including lipids and amino acids. These findings are consistent across different ancestries and genders.
Q2: How could these genetic metabolism findings contribute to new medical treatments?
By identifying genes that control blood metabolites and overlap with disease risk, the research offers new targets for drug development. For instance, the discovery that the VEGFA gene might control HDL cholesterol could lead to new medicines for preventing heart disease. Understanding and managing such metabolic disorders is crucial, and relevant expertise can be gained through diabetes and metabolic disorder care.
Q3: Where was this comprehensive study on metabolism genes conducted?
The study was a collaborative effort led by researchers at the Berlin Institute of Health at Charité-University Medicine Berlin, Germany, and Queen Mary University in London. It utilized genetic data from the UK Biobank.
References
- Study links 750 genes’ role in metabolism via impact on blood levels of molecules – ETHealthworld
- Study identifies hundreds of genes, including novel ones, governing blood molecule levels. News-Medical.net.
- Genetic Factors Shaping Human Metabolic Processes and their Effects on Health – Hilaris Publisher.
- An atlas of genetic influences on human blood metabolites – PMC.
- How genes affect our metabolism – Nachrichten aus der Wissenschaft » idw.
- How genes and small molecules influence our personal disease risk – Berlin Institute of Health (BIH).
- Atlas shows how genes affect our metabolism – Wellcome Sanger Institute.
- Study links 750 genes’ role in metabolism via impact on blood levels of molecules – ETHealthworld.
- Genetics of human metabolism: an update – PMC.
- The Mendelian randomization of Metabolomics and Cancer – UK Biobank.
- Biomarker profiling by NMR metabolomics for the study of chronic disease risk and underlying risk factors – UK Biobank.
- Metabolomic landscape of overall and common cancers in the UK Biobank: A prospective cohort study – PubMed.
- Tan, Y., & Timpson, N. J. (2022). The UK Biobank: A Shining Example of Genome-Wide Association Study Science with the Power – University of Bristol Research Portal.
- Genetic and metabolomic determinants of disease at population scale – World Congress of Epidemiology 2024.
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.
